Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 122,741 shares at $20.13 ($2.5M) on 2025-09-03, disclosed to the SEC on 2025-09-03.
Scheduled sale ($2.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.00 | 1,029 | $21K | 0.8% |
| 2 | $20.14 | 14,860 | $299K | 12.1% |
| 3 | $20.14 | 14,860 | $299K | 12.1% |
| 4 | $20.13 | 45,996 | $926K | 37.5% |
| 5 | $20.13 | 45,996 | $926K | 37.5% |
| Total | $20.13 avg | 122,741 |
| $2.5M |
| 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| STOK | SELL | 2025-12-03 | $65K | — | Filing → |